The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...